Kymera Therapeutics Inc (KYMR) — Financial Flexibility Index
Kymera Therapeutics Inc (KYMR) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of $-26.93 Million (operating CF $-27.11 Million minus capex $181.00K) represents 0% of total liabilities ($155.79 Million). Also explore KYMR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kymera Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Kymera Therapeutics Inc across 7 annual periods. Check KYMR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kymera Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Kymera Therapeutics Inc. For the full company profile including market capitalisation, see Kymera Therapeutics Inc (KYMR) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.28x | $-181.66 Million | $-194.50 Million | $142.42 Million | ▼ -237.4% |
| 2023 | -0.38x | $-68.35 Million | $-102.83 Million | $180.79 Million | ▲ +71.6% |
| 2022 | -1.33x | $-150.25 Million | $-153.09 Million | $112.98 Million | ▼ -52.7% |
| 2021 | -0.87x | $-127.35 Million | $-128.95 Million | $146.27 Million | ▼ -282.0% |
| 2020 | 0.48x | $97.23 Million | $88.13 Million | $203.29 Million | ▲ +395.7% |
| 2019 | 0.10x | $18.44 Million | $17.91 Million | $191.11 Million | ▲ +146.0% |
| 2018 | -0.21x | $-16.51 Million | $-17.86 Million | $78.67 Million | — |